Answer
Yes, Omjjara (momelotinib) is contraindicated in people with hypersensitivity to its active substance or any excipient listed in section 6.1.
Sources for this answer
- Omjjara 150 mg film-coated tabletsGlaxoSmithKline UK · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked